Cite
MLA Citation
Marisa O Peluso et al.. “The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a.” Journal for immunotherapy of cancer, vol. 8, no. 1, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127576051.0x000036